Abstract Details

Title SIAXI: Efficacy and safety of Xeomin (incobotulinumtoxinA) for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: Results of a Phase III, placebo-controlled, randomized, double-blind study

Topic Aging and Dementia

Presentation(s) S2 - (-)

Poster/Presentation
Number 007

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Wolfgang Jost PRESENTER	No disclosure on file
Andrzej Friedman, MD (Klinika Neurolog 11, UL Ban-)	No disclosure on file
	No disclosure on file
	No disclosure on file
Janos Csikós	No disclosure on file
Andrew Blitzer, MD	No disclosure on file